Peter Suenaert Email & Phone Number
CMO Hemispherian @ Hemispherian AS
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Peter Suenaert Location
- Ghent, BE
Peter Suenaert Work
- CMO Hemispherian @ (February 2025 - Present)
- Board Member @ (September 2023 - Present)
- Med Director @ The Akkermansia Company (former A-Mansia Biotech ) (August 2021 - Present)
- Founder and Owner (Chief Medical Officer and Clinical Advisor in Pharma and Biotech) @ SparkClin BV (January 2020 - Present)
- Clinical Advisor and former Chief Medical Officer (Immuno-Oncology) @ (May 2020 - September 2022)
- Vice President Head Global Clinical Development and Clinical Advisor (Immuno-Oncology) @ AgenTus Therapeutics (now MiNK Therapeutics) (October 2019 - April 2021)
- Chief Medical Officer (Immuno-Oncology) @ (June 2016 - September 2019)
- Senior Director Clinical Sciences (Immuno-Oncology) @ (October 2015 - June 2016)
- Global Head Clinical Development and Translational Research, R and D WWBU Dairy at Danone @ (May 2014 - August 2015)
- Director in Global Early Development Clinical Immunotherapeutics (Immuno-Oncology) @ (February 2011 - April 2014)
- Sr Clinical Scientist (Oncology) @ (September 2008 - February 2011)
- Sr Clinical Scientist (Oncology) @
- Medical Advisor Haematology and Oncology @ (March 2007 - August 2008)
- Staff Gastroenterology and GI Oncology @ (April 2005 - February 2007)
Peter Suenaert Education
- Institut Gustave Roussy
Postdoc (Oncology)
2005-2006 - McGill University
Postdoc (Gastroenterology & Oncology)
2003-2005 - KU Leuven
PhD (Medical sciences)
1999-2003 - KU Leuven
Internist (Internal Medicine & Gastroenterology)
1995-2003 - Medical Service of the Belgian Armed Forces
General practitioner (Family and Military Medicine)
1993-1995 - KU Leuven
MD (Medical School)
1986-1993 - McGill University
PostDoc
Peter Suenaert Skills
- Clinical Development
- Oncology
- Clinical Trials
- Immunology
- Clinical Research
- Drug Development
- Medical Affairs
- Translational Research
- Medicine
- Biotechnology
- Life Sciences
- In Vitro
- GCP
- Vaccines
- CTMS
- CRO
- In Vivo
- Drug Discovery
- Hematology
- Infectious Diseases
- Gastroenterology
- Biomarkers
- Medical Writing
- Lifesciences
- Cancer
- Biopharmaceuticals
- Internal Medicine
- Early Development
- Biotechnology Industry
- Translational Medicine
- Late phase clinical development
- Global Clinical Development
- ICH-GCP
- Pharmaceutical Industry
- R&D
- Research and Development (R&D)
- Good Clinical Practice (GCP)
- CRO Management
- Clinical Trial Management System Ctms
- Hospitals
- Customer Service
- Ich Gcp
- Global Clinical
- Chemistry
- Research and Development R&d
- Strategic Planning
- Late Phase Clinical
- Good Clinical Practice Gcp
- Good Clinical Practice
- Research and Development
- Clinical Trial Management System
Peter Suenaert Summary
- Peter Suenaert, based in Ghent, BE, is currently a CMO Hemispherian at Hemispherian AS. Peter Suenaert brings experience from previous roles at Sortina Pharma, The Akkermansia Company (former A-Mansia Biotech ), SparkClin BV and IMMUNICUM AB. Peter Suenaert holds a 2005 - 2006 Postdoc in Oncology @ Institut Gustave Roussy. With a robust skill set that includes Clinical Development, Oncology, Clinical Trials, Immunology, Clinical Research and more. Peter Suenaert has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Peter Suenaert?
Find contact details for 700 million professionals.
Others Named Peter Suenaert
Top Hemispherian AS Employees
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co